Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Patent: 6,177,074

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 6,177,074

Title:	Polyethylene glycol modified interferon therapy
Abstract:	A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
Inventor(s):	Glue; Paul (Flemington, NJ), Cutler; David L. (Morristown, NJ), Affrime; Melton B. (Flemington, NJ)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	09/281,401
Patent Claims:	see list of patent claims

Details for Patent 6,177,074

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	011	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	010	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	SYRINGE	103949	008	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	SYRINGE	103949	007	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 6,177,074

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
South Africa	9803543	Nov 10, 1998
World Intellectual Property Organization (WIPO)	9716204	May 09, 1997
World Intellectual Property Organization (WIPO)	9848840	Nov 05, 1998
United States of America	5908621	Jun 01, 1999
United States of America	6461605	Oct 08, 2002
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Medtronic

Merck

Johnson and Johnson

Harvard Business School

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.